Peter Svennilson Insider Trading $NGM NGM BIOPHARMACEUTICALS INC
Get free email notifications about insider trading for Peter Svennilson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Svennilson. Peter Svennilson is 10% Owner in NGM BIOPHARMACEUTICALS INC ($NGM) and Director in NGM BIOPHARMACEUTICALS INC ($NGM) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Immune Design Corp. ($IMDZ) and in RAPT Therapeutics, Inc. ($RAPT) and Director in RAPT Therapeutics, Inc. ($RAPT) and Director in Revolution Medicines, Inc. ($RVMD) and Director in Gritstone Oncology, Inc. ($GRTS) and Director in Oric Pharmaceuticals, Inc. ($ORIC).
Peter Svennilson in NGM BIOPHARMACEUTICALS INC
Trading Symbol: NGMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Svennilson: 10% Owner, Director
Holdings: 17,706,978 shares
Latest Transaction: Apr 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Svennilson in NGM BIOPHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNST, GRTS, IMDZ, NGM, ORIC, RAPT, RVMD
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.95 | 112,602 | 1,683,400 | 17,706,978 | 17.6 M to 17.7 M (+0.64 %) |
Apr 07 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.38 | 123,728 | 1,779,209 | 17,594,376 | 17.5 M to 17.6 M (+0.71 %) |
Apr 07 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.41 | 14,587 | 181,025 | 17,470,648 | 17.5 M to 17.5 M (+0.08 %) |
Apr 02 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.40 | 14,850 | 184,140 | 17,456,061 | 17.4 M to 17.5 M (+0.09 %) |
Apr 02 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.26 | 118,067 | 1,447,501 | 17,441,211 | 17.3 M to 17.4 M (+0.68 %) |
Apr 02 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.53 | 118,067 | 1,479,380 | 17,323,144 | 17.2 M to 17.3 M (+0.69 %) |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.49 | 2,416 | 30,176 | 17,205,077 | 17.2 M to 17.2 M (+0.01 %) |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.22 | 128,377 | 1,568,767 | 17,202,661 | 17.1 M to 17.2 M (+0.75 %) |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.63 | 170,387 | 1,981,601 | 17,074,284 | 16.9 M to 17.1 M (+1.01 %) |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.49 | 2,416 | 30,176 | 17,205,077 | 17.2 M to 17.2 M (+0.01 %) |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.22 | 128,377 | 1,568,767 | 17,202,661 | 17.1 M to 17.2 M (+0.75 %) |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.63 | 170,387 | 1,981,601 | 17,074,284 | 16.9 M to 17.1 M (+1.01 %) |
Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.77 | 143,082 | 1,684,075 | 16,903,897 | 16.8 M to 16.9 M (+0.85 %) |
Mar 23 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.59 | 148,464 | 1,720,698 | 16,760,815 | 16.6 M to 16.8 M (+0.89 %) |
Mar 06 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 18.00 | 8,307 | 149,526 | 16,612,351 | 16.6 M to 16.6 M (+0.05 %) |
Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.96 | 9,986 | 179,349 | 16,604,044 | 16.6 M to 16.6 M (+0.06 %) |
Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.99 | 38,758 | 697,256 | 16,594,058 | 16.6 M to 16.6 M (+0.23 %) |
Mar 04 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.90 | 14,124 | 252,820 | 16,555,300 | 16.5 M to 16.6 M (+0.09 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.91 | 37,800 | 676,998 | 16,541,176 | 16.5 M to 16.5 M (+0.23 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.91 | 33,896 | 607,077 | 16,503,376 | 16.5 M to 16.5 M (+0.21 %) |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 18.00 | 3,751 | 67,518 | 16,469,480 | 16.5 M to 16.5 M (+0.02 %) |
Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 15.96 | 44,900 | 716,604 | 16,465,729 | 16.4 M to 16.5 M (+0.27 %) |
Nov 13 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.00 | 15 | 180 | 16,420,829 | 16.4 M to 16.4 M (0.00 %) |
Nov 06 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.99 | 8,409 | 100,824 | 16,420,814 | 16.4 M to 16.4 M (+0.05 %) |
Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.86 | 2,087 | 24,752 | 16,412,405 | 16.4 M to 16.4 M (+0.01 %) |
Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.00 | 2,300 | 27,600 | 16,410,318 | 16.4 M to 16.4 M (+0.01 %) |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,408,018 | 16.4 M to 16.4 M (+0.27 %) |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,364,618 | 16.3 M to 16.4 M (+0.21 %) |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,329,897 | 16.3 M to 16.3 M (+0.04 %) |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,408,018 | 16.4 M to 16.4 M (+0.27 %) |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,364,618 | 16.3 M to 16.4 M (+0.21 %) |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,329,897 | 16.3 M to 16.3 M (+0.04 %) |
Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.26 | 34,900 | 358,074 | 16,323,079 | 16.3 M to 16.3 M (+0.21 %) |
Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.31 | 33,200 | 342,292 | 16,288,179 | 16.3 M to 16.3 M (+0.20 %) |
Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.36 | 34,900 | 361,564 | 16,254,979 | 16.2 M to 16.3 M (+0.22 %) |
Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 16,220,079 | 16.2 M to 16.2 M (+0.11 %) |
Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 16,202,355 | 16.2 M to 16.2 M (+0.11 %) |
Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 16,184,631 | 16.2 M to 16.2 M (+0.11 %) |
Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.99 | 152 | 2,126 | 16,166,907 | 16.2 M to 16.2 M (0.00 %) |
Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.98 | 12 | 168 | 16,166,755 | 16.2 M to 16.2 M (0.00 %) |
Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.00 | 224,500 | 3,143,000 | 16,166,743 | 15.9 M to 16.2 M (+1.41 %) |
Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.96 | 310 | 4,328 | 15,942,243 | 15.9 M to 15.9 M (0.00 %) |
Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.98 | 5,824 | 81,400 | 15,941,933 | 15.9 M to 15.9 M (+0.04 %) |
Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.97 | 1,782 | 24,898 | 15,936,109 | 15.9 M to 15.9 M (+0.01 %) |
Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.98 | 2,600 | 36,346 | 15,934,327 | 15.9 M to 15.9 M (+0.02 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.91 | 8,855 | 123,195 | 15,931,727 | 15.9 M to 15.9 M (+0.06 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.58 | 19,201 | 260,727 | 15,922,872 | 15.9 M to 15.9 M (+0.12 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.59 | 30,059 | 408,634 | 15,903,671 | 15.9 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.37 | 30,753 | 411,294 | 15,873,612 | 15.8 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.51 | 29,054 | 392,502 | 15,842,859 | 15.8 M to 15.8 M (+0.18 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.59 | 30,059 | 408,634 | 15,903,671 | 15.9 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.37 | 30,753 | 411,294 | 15,873,612 | 15.8 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.51 | 29,054 | 392,502 | 15,842,859 | 15.8 M to 15.8 M (+0.18 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.35 | 30,760 | 410,535 | 15,813,805 | 15.8 M to 15.8 M (+0.19 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.54 | 30,760 | 416,337 | 15,783,045 | 15.8 M to 15.8 M (+0.20 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.99 | 6,222 | 87,043 | 15,752,285 | 15.7 M to 15.8 M (+0.04 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.86 | 3,900 | 54,055 | 15,746,063 | 15.7 M to 15.7 M (+0.02 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.69 | 16,188 | 221,547 | 15,742,163 | 15.7 M to 15.7 M (+0.10 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,725,975 | 15.7 M to 15.7 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,704,961 | 15.7 M to 15.7 M (+0.07 %) |
Jun 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.78 | 12,240 | 168,650 | 15,694,091 | 15.7 M to 15.7 M (+0.08 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.03 | 3,763 | 52,789 | 15,681,851 | 15.7 M to 15.7 M (+0.02 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.86 | 15,400 | 213,385 | 15,678,088 | 15.7 M to 15.7 M (+0.10 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.91 | 15,214 | 211,674 | 15,662,688 | 15.6 M to 15.7 M (+0.10 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.00 | 10,760 | 150,687 | 15,647,474 | 15.6 M to 15.6 M (+0.07 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.13 | 11,500 | 162,508 | 15,636,714 | 15.6 M to 15.6 M (+0.07 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.00 | 7,500 | 104,989 | 15,625,214 | 15.6 M to 15.6 M (+0.05 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.83 | 10,900 | 150,718 | 15,617,714 | 15.6 M to 15.6 M (+0.07 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.66 | 12,600 | 172,176 | 15,606,814 | 15.6 M to 15.6 M (+0.08 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.40 | 12,600 | 168,884 | 15,594,214 | 15.6 M to 15.6 M (+0.08 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.39 | 12,600 | 168,764 | 15,581,614 | 15.6 M to 15.6 M (+0.08 %) |
May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.50 | 50,000 | 675,000 | 15,569,014 | 15.5 M to 15.6 M (+0.32 %) |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.85 | 17,923 | 248,234 | 15,519,014 | 15.5 M to 15.5 M (+0.12 %) |
May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.10 | 57,000 | 803,700 | 15,501,091 | 15.4 M to 15.5 M (+0.37 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 8,408,933 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | C | 0.00 | 13,093,134 | 0 | 15,444,091 | 2.4 M to 15.4 M (+556.93 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 2,350,957 | 476 K to 2.4 M (+393.94 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 16.00 | 20,000 | 320,000 | 20,000 | 0 to 20 K |
Page: 1